Combination therapy of voriconazole and terbinafine for disseminated fusariosis: Case report and literature review

Journal of Infection and Chemotherapy

Volumn 19, Issue 6, 2013, Pages 1173-1180

  Inano, Shojiro ^a   Kimura, Masahiro ^a   Iida, Jun ^a   Arima, Nobuyoshi ^a  

^a Kitano Hospital   (Japan)

Author keywords

Combination therapy; Endocarditis; Fusariosis; Fusarium; Terbinafine; Voriconazole

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; ITRACONAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TERBINAFINE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ASPERGILLOSIS; BONE MARROW EXAMINATION; CASE REPORT; CELLULITIS; CLINICAL FEATURE; COUGHING; DISEASE COURSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHEMA; FATIGUE; FEVER; FUNGAL DETECTION; FUSARIOSIS; FUSARIUM SOLANI; HEART LEFT VENTRICLE MASS; HUMAN; HYPOKALEMIA; LOADING DRUG DOSE; LUNG NODULE; MALE; PANCYTOPENIA; PLEURA EFFUSION; RECURRENT DISEASE; REVIEW; SKIN BIOPSY; SKIN NODULE;

ADULT; AGED; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FUSARIOSIS; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NAPHTHALENES; PYRIMIDINES; TRIAZOLES;

EID: 84890858044     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-013-0594-9     Document Type: Article

References (40)

1. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother. 2008;61:805-9.
2. Cornely OA, Schmitz K, Aisenbrey S. The first echinocandin: caspofungin. Mycoses. 2002;45(suppl 3):56.
3. Speeleveld E, Gordts B, Van Landuyt HW, De Vroey C, Raes-Wuytack C. Susceptibility of clinical isolates of Fusarium to antifungal drugs. Mycoses. 1996;39:37-40.
4. Azor M, Gené J, Cano J, Sutton DA, Fothergill AW, Rinaldi MG, et al. In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum. Antimicrob Agents Chemother. 2008;52:2228-31.
5. Furustrand TU, Meis JF, Trampuz A. Isothermal microcalorimetry for antifungal susceptibility testing of Mucorales, Fusarium spp., and Scedosporium spp. Diagn Microbiol Infect Dis. 2012;73:330-7.
6. Drogari-Apiranthitou M, Mantopoulou FD, Skiada A, Kanioura L, Grammatikou M, Vrioni G, Mitroussia-Ziouva A, et al. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs. Antimicrob Chemother. 2012;67:1937-40.
7. Campo M, Lewis RE, Korntoviannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect. 2010;60:331-7.
8. Nucci M, Anaissie EJ, Queiroz-Telles F, Martins CA, Trabasso P, Solza C, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer (Phila). 2003;98:315-9.
9. Córdoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents. 2008;31:171-4.
10. Ortoneda M, Capilla J, Javier Pastor F, Pujol I, Guarro J. In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diagn Microbiol Infect Dis. 2004;48:69-71.
11. Li L, Wang Z, Li R, Luo S, Sun X. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Am J Ophthalmol. 2008;146:724-8.
12. Spader TB, Venturini TP, Cavalheiro AS, Mahl CD, Mario DN, Lara VM, et al. In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp. Mycoses. 2011;54:131-6.
13. Shalit I, Shadkchan Y, Mircus G, Osherov N. In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp. Med Mycol. 2009;47:457-62.
14. Lau A, Sorrell TC, Chen S, Stanley K, Iredell J, Halliday C. Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol. 2008;46(9):3021-7.
15. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20:695-704.
16. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect. 1994;28(suppl 1):7.
17. Gamis AS, Gudnason T, Giebink GS, Ramsay NK. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis. 1991;13:1077-88.
18. Spader TB, Venturini TP, Cavalheiro AS, Mahl CD, Mario DN, Lara VM, et al. Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis. 1988;10:653.
19. Tortorano AM, Prigitano A, Dho G, Esposto MC, Gianni C, Grancini A, et al. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob Agents Chemother. 2008;52:2683.
20. Speeleveld E, Gordts B, Van Landuyt HW, De Vroey C, Raes-Wuytack C. Susceptibility of clinical isolates of Fusarium to antifungal drugs. Mycoses. 1996;39:37.
21. Fanci R, Pini G, Bartolesi AM, Pecile P. Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review. Rev Iberoam Micol. 2012;. doi: 10.1016/j.riam.2012.05. 003.
22. Liu JY, Chen WT, Ko BS, Yao M, Hsueh PR, Hsiao CH, et al. Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: a case report and literature review. Med Mycol. 2011;49:872-8.
23. Vagace JM, Sanz-Rodriguez C, Casado MS, Alonso N, Garcia-Dominguez M, de la Llana FG, Zarallo L, Fajardo M, Bajo R. Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report. BMC Infect Dis. 2007;10:40.
24. Stanzani M, Vianelli N, Bandini G, Paolini S, Arpinati M, Bonifazi F, et al. Successful treatment of disseminated fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect. 2006;53:e243-6.
25. Durand-Joly I, Alfandari S, Benchikh Z, Rodrigue M, Espinel-Ingroff A, Catteau B, et al. Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia. J Clin Microbiol. 2003;41:4898-900.
26. Rothe A, Seibold M, Hoppe T, Seifert H, Engert A, Caspar C, et al. Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann Hematol. 2003;83:394-7.
27. Guzman-Cottrill JA, Zheng X, Chadwick EG. Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole. Pediatr Infect Dis J. 2004;23:1059-61.
28. Neuburger S, Massenkeil G, Seibold M, Lutz C, Tamm I, le Coutre P, et al. Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation. Transpl Infect Dis. 2008;10:290-3.
29. Barrios NJ, Kirkpatrick DV, Murciano A, Stine K, Van Dyke RB, Humbert JR. Successful treatment of disseminated Fusarium infection in an immunocompromised child. Am J Pediatr Hematol Oncol. 1990;12:319-24.
30. Ho DY, Lee JD, Rosso F, Montoya JG. Treating disseminated fusariosis: amphotericin B, voriconazole or both? Mycoses. 2007;50:227-31.
31. Rodriguez CA, Luján-Zilbermann J, Woodard P, Andreansky M, Adderson EE. Successful treatment of disseminated fusariosis. Bone Marrow Transplant. 2003;31:411-2.
32. Cuellar-Rodriguez J, Bravo LT, Oethinger M, Fraser T, Mossad SB. Disseminated fusariosis in a recipient of a bone-marrow transplant. Lancet Infect Dis. 2009;9:520.
33. Bourgeois GP, Cafardi JA, Sellheyer K, Andea AA. Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature. Cutis. 2010;85:191-4.
34. Makowsky MJ, Warkentin DI, Savoie M. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia. Ann Pharmacother. 2005;39:1365-6.
35. Nunes Mdo C, Barbosa FB, Gomes GH, Bráulio R, Nicoliello MF, Ferrari TC. Fatal right-sided endocarditis caused by Fusarium in an immunocompromised patient: a case report. Mycoses 2011;54:460-462.
36. Camin AM, Michelet C, Langanay T, de Place C, Chevrier S, Guého E, et al. Endocarditis due to Fusarium dimerum four years after coronary artery bypass grafting. Clin Infect Dis. 1999;28:150.
37. Guinvarc'h A, Guilbert L, Marmorat-Khuong A, Lavarde V, Chevalier P, Amrein C, et al. Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient. Mycoses. 1998;41:59-61.
38. Hsu CM, Lee PI, Chen JM, Huang LM, Wu MH, Chiu IS, et al. Fatal Fusarium endocarditis complicated by hemolytic anemia and thrombocytopenia in an infant. Pediatr Infect Dis J. 1994;13:1146-8.
39. Jorens PG, Van Den Heuvel PA, Van Cauwelaert PA, Parizel GA, Mertens AN. Fusarium endocarditis involving aortic valve following coronary artery surgery. Eur Heart J. 1990;11:476-8.
40. Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL, et al. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother. 2010;54:4446-50.